CardioNerds Journal Club Profile Banner
CardioNerds Journal Club Profile
CardioNerds Journal Club

@CardioNerdsJC

Followers
8,192
Following
848
Media
644
Statuses
1,539

A monthly #Cardiology journal club that meets on Twitter produced by @CardioNerds ‼️ Use #CardsJC & join the conversation!

Joined January 2021
Don't wanna be here? Send us removal request.
Explore trending content on Musk Viewer
@CardioNerdsJC
CardioNerds Journal Club
3 years
To date, there have been many studies in HFpEF utilizing novel meds, but very few that exhibited significant benefit in this patient population. Would anything change this troubling streak? #CardsJC
Tweet media one
1
41
128
@CardioNerdsJC
CardioNerds Journal Club
3 years
Hey there! ♥️🤓 @CardioNerds everywhere, the October @CardioNerdsJC is starting in 30 minutes! Let's discuss the EMPEROR - Preserved trial. Do SGLT2 Inhibitors improve outcomes in HFpEF? #CardsJC #HouseJones
Tweet media one
0
17
103
@CardioNerdsJC
CardioNerds Journal Club
3 years
Although HFpEF and HFrEF have similarly poor outcomes, HFpEF trials have consistently failed to show a reduction in morbidity and mortality. Here’s a quick overview of the major HFpEF 📜trials by @CardioNerds Academy Fellow @OAmidiMD #HouseEinthoven #CardsJC
Tweet media one
2
34
89
@CardioNerdsJC
CardioNerds Journal Club
1 year
Now for #ELAN trial! 🔹 Multicenter open label randomized trial 🔹 2013 participants 🔹 Aim ➡️ to evaluate the safety & efficacy of early vs late initiation of DOACs in patients with acute ischemic stroke 🧠 who have atrial fibrillation 🫀 #CardsJC
Tweet media one
0
20
69
@CardioNerdsJC
CardioNerds Journal Club
3 years
Let’s dive a little deeper into the background! #CardsJC
Tweet media one
2
27
70
@CardioNerdsJC
CardioNerds Journal Club
4 years
Check out this table summary of relevant Omega-3 RCTs! Has your practice changed based on these trials? #CardsJC
Tweet media one
5
30
64
@CardioNerdsJC
CardioNerds Journal Club
3 years
The patient is rushed to the cath lab. You get access and quickly engage the coronaries to see what you are dealing with. #CardsJC ❓What do you see in the angiogram? What is the culprit vessel? What do you think about the complexity of the lesions seen?
Tweet media one
18
9
61
@CardioNerdsJC
CardioNerds Journal Club
3 years
Contrast this with HFrEF, for which numerous life-prolonging ⌛️ strategies are available. Check out an overview of these treatments for HFrEF by @CardioNerds fellow @TDonisan #HouseTaussig #CardsJC
Tweet media one
2
19
62
@CardioNerdsJC
CardioNerds Journal Club
2 years
Join us for the first @CardioNerds journal club of ✨2023✨ we'll be discussing ECMO-CS trial! ⏰ Tonight at 8 pm EST 📍 @CardioNerdsJC #CardsJC Check out our article summary and visual abstract ⬇️⬇️
Tweet media one
0
24
60
@CardioNerdsJC
CardioNerds Journal Club
3 years
Check out the article summary & the amazing visual abstract created by @TDonisan . #CardsJC
Tweet media one
2
17
59
@CardioNerdsJC
CardioNerds Journal Club
3 years
How do SGLT2 inhibitors fit into the evolution of HF GDMT? #CardsJC
Tweet media one
2
12
58
@CardioNerdsJC
CardioNerds Journal Club
3 years
Rate vs rhythm control is an old controversy – initial trials found no differences in either strategy w/ regards to MACE, but newer studies reveal benefits for rhythm control. #CardsJC ❓Any other rate/rhythm control trials that you've based your practice on?
Tweet media one
7
14
55
@CardioNerdsJC
CardioNerds Journal Club
1 year
The @CardioNerds are back again with a new #CardsJC Journal Club!! 🤩🎉 Join us on twitter Thursday🗓️, 7/27/23, 8:00 PM EST🕗in our🔥discussion on the #ELAN trial🫀 Get the inside scoop from our experts to help you decide when to start AC💊in your patients with stroke🧠and AF🫀
Tweet media one
0
19
57
@CardioNerdsJC
CardioNerds Journal Club
1 year
⛱️ @CardioNerds is kicking off the 🌞season with a new #CardsJC Journal Club. Join us on Twitter this Thursday, 6/29 at 8pm EST. Several experts will join us for a 🔥discussion on the #RapidHF trial: this one has something for everyone- from #HFpEF to #EP ! See you there! 🫀🌞🌊
Tweet media one
1
29
54
@CardioNerdsJC
CardioNerds Journal Club
3 years
✏️LoDoCo trial (2013): Colchicine dec. risk of CV events in stable CAD (open label) ✏️CANTOS trial (2017): Canakimumab (IL-1β inhibitor): CV events lower compared to placebo ✏️COLCOT trial (2019): Colchicine improved CV outcomes in pt w/ recent MI #CardsJC
Tweet media one
0
22
53
@CardioNerdsJC
CardioNerds Journal Club
3 years
Final food🥕🥕 for thought💭💭!! An incredible editorial @NEJM explains multiple pathways for salt excretion #CardsJC #SSaSS
Tweet media one
0
19
53
@CardioNerdsJC
CardioNerds Journal Club
2 years
Didn’t have a chance to read CANARY? 🦜 We’ve got you covered! Check out this awesome visual abstract created by @DocBrilliant and reviewed by our chief @TDonisan and #CardsJC director @DeveshRaiMD . The full-text article can be found here ➡️
Tweet media one
3
27
54
@CardioNerdsJC
CardioNerds Journal Club
3 years
Check out the EARLY-AF and STOP-AF article summaries by @dinubalaescu and @Gurleen_Kaur96 ( to @DrRachitaEP & @AjayPMD for peer review). Don’t miss the iconic visual abstract created by @OAmidiMD #CardsJC
Tweet media one
Tweet media two
2
14
53
@CardioNerdsJC
CardioNerds Journal Club
2 years
Before we get too wrapped up in the #CardsJC , please help us give a warm welcome to @DeveshRaiMD , who is the new director of the Journal Club for @CardioNerds
Tweet media one
2
9
53
@CardioNerdsJC
CardioNerds Journal Club
3 years
Your clinic patient has chronic, stable coronary artery disease. You've maximized their anti-platelets 🩸, statin 🧡,beta-blocker 💊, but you'd like to reduce their cardiovascular risk further. What can you do? #CardsJC
21
4
51
@CardioNerdsJC
CardioNerds Journal Club
2 years
Hello! ♥️🤓 @CardioNerds is bringing you an AMAZING @CardioNerdsJC in 30 minutes! Let's discuss the ISAR-REACT 5 trial. Ticagrelor vs Prasugrel in ACS?? #CardsJC #HouseTaussig
Tweet media one
0
13
48
@CardioNerdsJC
CardioNerds Journal Club
3 years
It is 2 am. In the midst of your sleep, the pager beeps. 😴📟 – “ED page – STEMI” You are sent the EKG. How would you like to proceed? #CardsJC - Call & get the hx, vitals, & pt’s current status - Admit to CCU for monitoring/med mgmt - Go back to sleep, likely false activation
Tweet media one
14
12
47
@CardioNerdsJC
CardioNerds Journal Club
2 years
Didn’t have a chance to read ECMO-CS? Check out our visual abstract and article summary! #CardsJC
Tweet media one
0
15
44
@CardioNerdsJC
CardioNerds Journal Club
9 months
🚨Attention all @CardioNerds !! Join #HouseTaussig 🫀and a panel of phenomenal experts tomorrow at 8:00 PM EST to discuss the revolutionary results of #SELECT 🔥 An absolute gamechanger!🤩 Can't wait to see you then! 🕗
Tweet media one
0
25
45
@CardioNerdsJC
CardioNerds Journal Club
6 months
It's almost⏲️for this months #CardsJC ! Come hang out and discuss #ORBITA2 with this stellar group of nerds. When: Tomorrow, 2/29, at 8PM EST. Where: Here! #CardsJC We can't wait to 👀you there
Tweet media one
0
13
44
@CardioNerdsJC
CardioNerds Journal Club
1 year
Join us tomorrow @CardioNerdsJC to discuss TRILUMINATE Trial with an incredible panel of experts 📅April 27, 8 PM EST🕗 on Twitter only #CardsJC @tavrkapadia @hahn_rt @DrHurshNaik @AndreaScotti21 @Almanfi_Cardio @SachinGoelMD @SergeHarbMD @whisenant_brian
Tweet media one
0
16
42
@CardioNerdsJC
CardioNerds Journal Club
3 years
The benefits of complete revascularization after a STEMI has been an ongoing topic of trials, with most showing benefits to revascularization in the absence of cardiogenic shock, either w/ FFR or angiographic guidance #CardsJC Any other trial worth highlighting?
Tweet media one
2
12
40
@CardioNerdsJC
CardioNerds Journal Club
3 years
To get situated: check out this powerful 👊🏼visual abstract crafted by our one and only @IsaMathiasMD The full text article can be found at NEJM: 📰 #CardsJC
Tweet media one
0
15
40
@CardioNerdsJC
CardioNerds Journal Club
2 years
We are fellows @RawanAAmir @BhavyaVarma12 @The_Doc_Martin @KateAltaWilcox @Shivanireddy_1 , and chief @A_H_Ghoneem for #HouseTaussig . We'll be your hosts; we have no COI. Again, remember to use #CardsJC in your tweets!
Tweet media one
Tweet media two
2
18
40
@CardioNerdsJC
CardioNerds Journal Club
3 years
A BIG THANKS to our @Cardionerds Ambassadors @mapabonp ( @BrighamFellows ) & @kellyarps ( @DukeCardFellows ) for all their help with this #CardsJC !
Tweet media one
Tweet media two
2
10
39
@CardioNerdsJC
CardioNerds Journal Club
3 years
What a phenomenal Clubhouse talk moderated by @EvelynSongMD and driven by guest faculty and FIT. @CardioNerds #HouseEinthoven thank you for not only preserving the discussion, but turning it into high output! Looking forward to our next @CardioNerdsJC #CardsJC discussion!
Tweet media one
1
6
38
@CardioNerdsJC
CardioNerds Journal Club
3 years
Enter: SGLT2 inhibitors. The data has been robust, including for patients with heart failure! But what about HFpEF? EMPEROR-PRESERVED answered this by evaluating the SGLT2i empagliflozin 10mg daily vs placebo in patients with EF>40% #CardsJC
Tweet media one
Tweet media two
1
7
39
@CardioNerdsJC
CardioNerds Journal Club
1 year
Didn’t have a chance to get to CLEAR? No problem! Check out our visual abstract and article summary! Remember to include #CardsJC in your tweets!
Tweet media one
3
12
36
@CardioNerdsJC
CardioNerds Journal Club
2 years
But first: check out this amazing visual abstract created by @AshishCorrea with review by @dranulala . The full text article can be found at The Lancet: 📰 . Here is our article summary! #CardsJC
Tweet media one
0
19
39
@CardioNerdsJC
CardioNerds Journal Club
3 years
Hey there! ♥️🤓 @CardioNerds everywhere, the December @CardioNerdsJC is starting in 30 minutes! Let's discuss the Salt Substitution trial. Does salt substitution safely improve cardiovascular outcomes? #CardsJC #HouseThomas #CardsJC #SSaSS
Tweet media one
0
10
39
@CardioNerdsJC
CardioNerds Journal Club
2 years
Didn’t have a chance to read ADVOR? We got you covered. Check out the amazing visual abstract created by @Gurleen_Kaur96 , with review by chief @jholtzman3 & director @DevesRaiMD . The full text article can be found here: #CardsJC
Tweet media one
1
22
37
@CardioNerdsJC
CardioNerds Journal Club
3 years
And now to discuss our article #CardsJC COMPLETE: A multinational, randomized, parallel, comparative effectiveness trial. Staged non-culprit PCI post STEMI + 💊 Vs No revascularization of non-culprits + 💊 4041 patients with median follow up of 3 years
Tweet media one
0
11
37
@CardioNerdsJC
CardioNerds Journal Club
3 years
If you didn’t get a chance to read the original FAME 3 trial, please check out our visual abstract and article summary! #CardsJC #FAME3
Tweet media one
0
11
37
@CardioNerdsJC
CardioNerds Journal Club
2 years
Check out the amazing visual abstract created by @anjaliagarwalla , with review by chief @jholtzman3 & director @DevesRaiMD . The full text article can be found here: #CardsJC
Tweet media one
1
19
37
@CardioNerdsJC
CardioNerds Journal Club
1 year
Great infographic by @JuliettePower44PAH on PAH therapies w/ proven clinical benefits What is your practice regarding PAH treatment? PH podcasts #CardsJC
Tweet media one
2
22
37
@CardioNerdsJC
CardioNerds Journal Club
3 years
Our brilliant friends over at @NephJC created this fantastic visual abstract for their recent discussion, as well! #SSaSS #NephJC @nefron1310 @kidney_boy @Nephro_Sparks
Tweet media one
0
13
35
@CardioNerdsJC
CardioNerds Journal Club
3 years
Here’s an overview of trials associated with ablation and AF:
Tweet media one
0
6
36
@CardioNerdsJC
CardioNerds Journal Club
3 years
Decreases in dietary Na+ and increases in dietary K+ have both been associated with reduced SBP and DBP, as well as improved CVD outcomes. #CardsJC #SSaSS @DrNeilStone @VietHeartPA @AnastasiaSMihai @cingolani_oscar @SethShayMartin @seamuswhelton @BrunoLimaMDPhD @AlizaHussainMD
Tweet media one
3
12
34
@CardioNerdsJC
CardioNerds Journal Club
7 months
Didn’t get a chance to read the ARTESIA trial? No worries! Check out our visual abstract and article summary! Remember to include #CardsJC in your tweets.
1
14
35
@CardioNerdsJC
CardioNerds Journal Club
2 years
Thank you so much to the wonderful team of @CardioNerds #HouseThomas for this amazing night of #CardsJC discussing ECMO-CS! ♥️🔝🙌🏼
Tweet media one
2
8
33
@CardioNerdsJC
CardioNerds Journal Club
3 years
A BTS pic of the @CardioNerds team behind the #CardsJC tonight! Everyone involved had a BLAST! Thank you to all our faculty members, #FITs and audience who enriched our discussion!
Tweet media one
1
6
33
@CardioNerdsJC
CardioNerds Journal Club
3 years
If you didn’t get a chance to read the original PARAGON-HF Trial article, please check out our 🎨visual abstract and 📜article summary! #CardsJC
Tweet media one
1
11
33
@CardioNerdsJC
CardioNerds Journal Club
2 years
Hello! ♥️🤓 @CardioNerds is bringing you an AMAZING @CardioNerdsJC in 30 minutes! We will be discussing the CHAP trial. To treat or not treat mild chronic HTN during pregnancy? #CardsJC #HouseTaussig
Tweet media one
0
13
32
@CardioNerdsJC
CardioNerds Journal Club
3 years
Terrific time discussing the FAME 3 trial with the @cardionerds and @CardioNerdsJC backstage! Thank you everyone for tuning in, and look forward to seeing you at the next #CardsJC !
Tweet media one
1
4
31
@CardioNerdsJC
CardioNerds Journal Club
2 years
Didn’t get a chance to read REVIVED-BCIS2? Check out the visual abstract and article summary! #CardsJC
Tweet media one
0
15
32
@CardioNerdsJC
CardioNerds Journal Club
3 years
If you didn’t get a chance to read the original trial article, please check out our visual abstract and article summary! #CardsJC
0
7
30
@CardioNerdsJC
CardioNerds Journal Club
1 year
Sotatercept (new drug class) w/ distinct mechanism than current therapies. It’s a fusion protein of activin receptor type IIa that traps TGF-B superfamily members rebalancing PA homeostasis #CardsJC
Tweet media one
1
7
30
@CardioNerdsJC
CardioNerds Journal Club
4 years
Thank you for being an incredible audience and for being #CardioNerds ! @TDonisan and @PatrickZakka signing off for #CardsJC . See you next time!
Tweet media one
Tweet media two
3
4
30
@CardioNerdsJC
CardioNerds Journal Club
1 year
Didn’t get a chance to read the STELLAR trial? No worries! Check out our visual abstract and article summary! Remember to include #CardsJC in your tweets.
Tweet media one
1
14
30
@CardioNerdsJC
CardioNerds Journal Club
3 years
Twitter Journal Club Archive for SOLOIST-WHT trial is out thanks to @PatrickZakka - if you missed the event- check out the highlights & key takeaways!
Tweet media one
Tweet media two
Tweet media three
2
8
29
@CardioNerdsJC
CardioNerds Journal Club
1 year
Join us tomorrow for #CardsJC for TRILUMINATE Trial discussion at 8 PM EST on Twitter only!! Review the incredible infographic by @KarlaAsturias and @hanchateshivani and amazing #CardsJC planned by House Thomas and House Einthoven of @cardionerds Academy #CardioTwitter
Tweet media one
1
17
29
@CardioNerdsJC
CardioNerds Journal Club
1 year
To date, RCTs evaluating different PAH therapies have shown a variable degree of relevant clinical outcomes improvement. The best PAH treatment regimen remains debatable. #CardsJC
Tweet media one
0
11
29
@CardioNerdsJC
CardioNerds Journal Club
3 years
Another great #CardsJC night with #HouseTaussig & @Cardionerds . Hope you had as much fun as we did. Thank you, everyone!
Tweet media one
0
11
29
@CardioNerdsJC
CardioNerds Journal Club
3 years
Let’s set the stage! This terrific visual abstract by the talented @jholtzman3 provides a great overview of the FAME 3 Trial. The full text article can be found at NEJM: 📰    #CardsJC #FAME3
Tweet media one
0
14
28
@CardioNerdsJC
CardioNerds Journal Club
2 years
Here we go with question 1! EXPLORER-HCM and VALOR-HCM are the first trials exploring #Mavacamten as a treatment of obstructive HCM. What are the most notable differences between EXPLORER-HCM and VALOR-HCM? #CardsJC @DesaiMilindY @SrihariNaiduMD @gcfmd @iamritu
Tweet media one
Tweet media two
5
13
28
@CardioNerdsJC
CardioNerds Journal Club
3 years
PARADIGM-HF found a significantly decreased risk of ☠️ death in HFrEF patients treated with sacubitril-valsartan vs enalapril. #CardsJC
Tweet media one
1
5
28
@CardioNerdsJC
CardioNerds Journal Club
4 years
Thanks for all the help from our incredible panel of experts #CardsJC
Tweet media one
2
2
28
@CardioNerdsJC
CardioNerds Journal Club
2 years
Get ready for @CardioNerds to discuss STRONG-HF! 💪 @CardioNerdsJC right here in 30 minutes! Is rapid up-titration of GDMT before and shortly after discharge from an acute heart failure admission effective and safe? #CardsJC #HouseEinthoven
Tweet media one
1
7
27
@CardioNerdsJC
CardioNerds Journal Club
3 years
Tweet media one
0
8
26
@CardioNerdsJC
CardioNerds Journal Club
2 years
✅ The trial included patients with rapidly deteriorating ( @SCAI D-E) or severe cardiogenic shock, meeting at least one hemodynamic and metabolic criteria, along with exclusion of hypovolemia. 📚 #CardsJC
Tweet media one
Tweet media two
1
4
26
@CardioNerdsJC
CardioNerds Journal Club
1 year
Let’s get started with RAPID-HF! Chronotropic incompetence is common in pts w/ HFpEF & a potential driver of exercise intolerance. Rate-adaptive pacing is a IIa, expert consensus recommendation for symptom management. #CardsJC
Tweet media one
3
8
26
@CardioNerdsJC
CardioNerds Journal Club
3 years
Happening tonight!!!
Tweet media one
Tweet media two
@CardioNerds
CardioNerds
3 years
Are you ready for the next #CardsJC ⁉️ Join the @CardioNerds Journal Club to discuss: 💊🫀PARAGON-HF 🌟Tue, May 11th: 🕗8pm EST on Twitter 🕘9pm on Clubhouse: In collaboration w/ @HFSA 🤝 Follow @CardioNerdsJC & tag " #CardsJC " ❤️🤓
Tweet media one
5
39
122
0
13
26
@CardioNerdsJC
CardioNerds Journal Club
3 years
Greetings! ♥️🤓 @CardioNerds everywhere, the January @CardioNerdsJC is starting in 30 minutes! Let's discuss the FAME 3 Trial. Is FFR-guided PCI noninferior to CABG for revascularization of patients w/3v-CAD? #CardsJC #HouseThomas #FAME3
Tweet media one
1
8
25
@CardioNerdsJC
CardioNerds Journal Club
2 years
If you didn’t get a chance to read the original SURMOUNT trial, please check out our visual abstract and article summary! #CardsJC
Tweet media one
0
11
25
@CardioNerdsJC
CardioNerds Journal Club
1 year
Tweet media one
1
11
23
@CardioNerdsJC
CardioNerds Journal Club
4 years
Thanks to @ASPCardio for this collaboration and to @DrMarthaGulati for mentorship in making our first @cardionerds #CardsJC a reality!
1
3
25
@CardioNerdsJC
CardioNerds Journal Club
2 years
Before we begin – here is the visual abstract by @The_Doc_Martin to get you up to speed! Link to @Cardionerds summary: The full text article can be found at NEJM: 📰 #CardsJC
Tweet media one
0
10
25
@CardioNerdsJC
CardioNerds Journal Club
9 months
Don’t have time to read the full NEJM article? Don’t fret! Check out this rad visual abstract by @CardioNerds fellow extraordinaire @BrainmanM #CardsJC
Tweet media one
1
8
25
@CardioNerdsJC
CardioNerds Journal Club
2 years
Get ready @CardioNerds to discuss REVIVED-BCIS2! @CardioNerdsJC starting in 30 minutes! ♥️ Does percutaneous revascularization for ischemic left ventricular dysfunction improve mortality and HF? #CardsJC #HouseEinthoven
Tweet media one
0
8
24
@CardioNerdsJC
CardioNerds Journal Club
1 year
Tweet media one
2
13
24
@CardioNerdsJC
CardioNerds Journal Club
4 months
It's almost⏲️for this months #CardsJC ! Come hang out with us to discuss one of the🔥trials of the year, #ULTIMATEDAPT with this stellar group of nerds! When🕗: Tomorrow 5/9, 8PM EST. We can't wait to see you there!! #CardsJC
Tweet media one
0
12
24
@CardioNerdsJC
CardioNerds Journal Club
9 months
🔥Join us tonight for #CardsJC to discuss the #STEPHFPEF trial with an incredible team of experts at 8 PM EST 🕗 Planned by #HouseThomas @ryantedfordmd @DrMarthaGulati @gcfmd @RBPatelMD @WilsonTangMD @VietHeartPA @AshishCorrea
Tweet media one
1
9
24
@CardioNerdsJC
CardioNerds Journal Club
2 years
Didn’t have a chance to read STRONG-HF? We got you covered. Check out the amazing visual abstract created by @TySweeney6 , with review by chief @jholtzman3 & #CardsJC director @DevesRaiMD . The full text article can be found here:
Tweet media one
0
15
24
@CardioNerdsJC
CardioNerds Journal Club
2 years
Let’s get started! Loop diuretics remain a mainstay of decongestion in acute decompensated heart failure. When do you find yourself reaching for sequential diuretic therapy (e.g. adding on acetazolamide)? #CardsJC
Tweet media one
6
3
22
@CardioNerdsJC
CardioNerds Journal Club
3 years
You just diagnosed your patient with HFpEF. What is your go-to initial treatment and why? #CardsJC
MRA
137
ACEI/ARB
164
Diuretic
214
Other (reply!)
30
9
9
21
@CardioNerdsJC
CardioNerds Journal Club
1 year
Tweet media one
3
6
22
@CardioNerdsJC
CardioNerds Journal Club
3 years
Thank you for being an incredible audience and for being #CardioNerds ! Najah Khan @najahakhan and Ahmed Ghoneem @a_h_ghoneem , signing off for #CardsJC . See you next time!
Tweet media one
Tweet media two
0
3
23
@CardioNerdsJC
CardioNerds Journal Club
3 years
You just diagnosed your patient with new-onset AF. What is your go-to initial treatment and why? #CardsJC
Rate Control
223
Rhythm Control
287
Cardioversion
198
Other?
47
14
8
23
@CardioNerdsJC
CardioNerds Journal Club
3 years
If you didn’t get a chance to read the original Salt Substitution trial, please check out our visual abstract and article summary! #CardsJC #SSaSS 🧂🧂 👀👀Visual abstract by @HussainMKCards 📜📜Article summary by @jholtzman3
Tweet media one
1
10
22
@CardioNerdsJC
CardioNerds Journal Club
6 months
Let's start with a question re: inclusion criteria. Patients included in the trial were specifically NOT taking anti-anginals. Why was this important to establish? Does this impact generalizability? #CardsJC
Tweet media one
6
6
22
@CardioNerdsJC
CardioNerds Journal Club
3 years
⚡ Early-rhythm control therapy ⚡ in patients with early AF was associated with ↘️ CV death, stroke, or hospitalization for HF or ACS than usual care (absolute difference in risk, 1.1 events per 100 person-years) #CardsJC
1
3
22
@CardioNerdsJC
CardioNerds Journal Club
1 year
✨ To get your juices flowing, take a look at this outstanding visual abstract crafted by star fellows @KarlaAsturias and @HanchateShivani Please click below to see the full-text article: #CardsJC
Tweet media one
0
7
21
@CardioNerdsJC
CardioNerds Journal Club
3 years
❌ No difference between 💊rate and ⚡ rhythm control with regards to: •Number of nights spent in the hospital (2nd primary outcome) •Symptoms, quality of life, and LV function at 2 years •Cognitive function. ❓ Is this result surprising to you? #CardsJC
Tweet media one
6
5
21
@CardioNerdsJC
CardioNerds Journal Club
3 years
...Also, effects were noted to be statistically significant within one month of use in the acute population. NNT 4. #CardsJC
Tweet media one
1
5
21
@CardioNerdsJC
CardioNerds Journal Club
4 years
We're👩🏼‍⚕️ @TDonisan and👨🏻‍⚕️ @PatrickZakka , @CardioNerds Academy Fellows, #HouseTaussig , We'll be your hosts for this Journal Club, we have no COI. We want to hear from all of you, so tag your tweets with #CardsJC . Introduce yourselves and declare any COI.
Tweet media one
2
10
22
@CardioNerdsJC
CardioNerds Journal Club
4 years
Don’t forget to review this “how-to” guide by @RichardAFerraro #CardsJC
Tweet media one
1
6
21
@CardioNerdsJC
CardioNerds Journal Club
8 months
Will the #SELECT trial change your practice? 🥼 Will you start prescribing GLP-1 agonist to your patients with preexisting CV disease & elevated BMI even without history of diabetes? 💊 #CardsJC
Tweet media one
8
4
19
@CardioNerdsJC
CardioNerds Journal Club
2 years
Let’s go to the results! 117 patients were randomized ➡️ Immediate VA-ECMO: 58 ➡️ Early conservative therapy: 59 🚨 Cross-over from conservative therapy to VA-ECMO: 39% 🚨 #CardsJC
Tweet media one
Tweet media two
3
8
21